Genomic Health, Inc. (NASDAQ:GHDX)

CAPS Rating: 4 out of 5

A life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions.

Results 1 - 20 of 42 : 1 2 3 Next »

Recs

0
Member Avatar acekeldog (99.80) Submitted: 3/11/2016 3:15:12 PM : Outperform Start Price: $32.79 GHDX Score: -36.20

I suggest these junior money losers try to get their secondary stock offerings in soon.

Recs

0
Member Avatar wmansvelt (31.76) Submitted: 12/21/2015 2:59:18 PM : Outperform Start Price: $34.24 GHDX Score: -30.09

Long term trend will require more and more use of DNA or genomic assessments.

Recs

0
Member Avatar Tophinater (< 20) Submitted: 9/19/2014 12:01:12 AM : Outperform Start Price: $29.08 GHDX Score: -16.97

I don't know.

Recs

0
Member Avatar PatientJC (35.49) Submitted: 2/10/2014 11:40:55 AM : Outperform Start Price: $26.38 GHDX Score: -20.66

Superior fundamentals

Recs

0
Member Avatar legofkan1 (< 20) Submitted: 11/9/2013 11:07:35 AM : Outperform Start Price: $34.98 GHDX Score: -45.28

EXPANDING!

Recs

0
Member Avatar iksnamyzs (67.84) Submitted: 1/6/2013 1:10:27 PM : Outperform Start Price: $27.75 GHDX Score: -51.73

guy on dip

Recs

1
Member Avatar FoolishDane (< 20) Submitted: 11/20/2012 9:27:36 AM : Outperform Start Price: $26.83 GHDX Score: -55.71

A single treatment won't work for everyone, so there's definite promise in a company working to perfect tests so that individualized treatments may be prescribed. This would result in less frustration for the patient and his/her family and, hopefully, better survival rates.

Recs

0
Member Avatar TMFHumbleServant (92.85) Submitted: 11/20/2012 7:38:03 AM : Outperform Start Price: $26.83 GHDX Score: -55.71

Genomics will continue to play a bigger role in the future of medicine and treatments.

Recs

0
Member Avatar TMFPoinkie (97.79) Submitted: 11/7/2012 11:45:04 AM : Outperform Start Price: $28.61 GHDX Score: -60.42

Strong insider buys & strength of colon/protate cancer tests could eliminate chemo. Long

Recs

0
Member Avatar clymerjones (51.87) Submitted: 9/5/2012 10:47:49 PM : Outperform Start Price: $35.36 GHDX Score: -74.91

There is no more important health issue than getting treatments right in the fight against cancer and GHDX has the best if those tools right now. I expect their research to continue and that should them keep them in a leadership position.

Recs

0
Member Avatar TMFBoiseKen (93.89) Submitted: 7/3/2012 12:49:33 PM : Outperform Start Price: $35.86 GHDX Score: -80.68

I'd love to get it a little cheaper, but I think it can outperform over 5-10 years from here.

Recs

0
Member Avatar pthammond (26.10) Submitted: 6/15/2010 6:59:21 PM : Outperform Start Price: $14.38 GHDX Score: -12.58

A whole new way to diagnose that has to catch on. With limited competition, this company will do well.

Recs

1
Member Avatar gt1135 (33.30) Submitted: 2/10/2010 9:49:51 AM : Outperform Start Price: $16.95 GHDX Score: -45.77

Sitting near 52 week low. It won't last. Wish I had more real $$ to invest in this one at the moment.

Recs

1
Member Avatar simonhs (< 20) Submitted: 2/9/2010 7:28:05 PM : Outperform Start Price: $17.09 GHDX Score: -47.27

Aging population, more and more cancer. Might as well make some money off it.

Recs

1
Member Avatar scoobamang (< 20) Submitted: 11/25/2009 10:52:00 PM : Outperform Start Price: $18.80 GHDX Score: -58.01

Revenue increasing at a very nice clip, about to climb out of the red and into profitability, nice cash cushion. Life science sounds sexy.

Recs

1
Member Avatar neilphipps (< 20) Submitted: 6/23/2009 4:31:02 PM : Outperform Start Price: $16.48 GHDX Score: -80.02

Genomics is a promising direction for genetic studies.

Recs

1
Member Avatar Cab53RobertMsnG (82.58) Submitted: 5/28/2009 2:12:13 PM : Outperform Start Price: $19.05 GHDX Score: -98.62

GHDX

Recs

1
Member Avatar jajex1 (34.31) Submitted: 5/12/2009 9:52:38 AM : Outperform Start Price: $19.66 GHDX Score: -102.13

fransgeraedts pick

Recs

1
Member Avatar SmallPimpin (37.06) Submitted: 5/6/2009 8:14:03 PM : Outperform Start Price: $19.60 GHDX Score: -96.96

Mmm...medical tests...

Recs

1
Member Avatar jdwoollard (< 20) Submitted: 10/13/2008 6:12:51 PM : Outperform Start Price: $21.00 GHDX Score: -83.50

This company allows for targeted treatment of breast cancer. By better determining patients that will benefit from chemotherapy, there are substantial benefits for the patient and for the payors.

Results 1 - 20 of 42 : 1 2 3 Next »

Featured Broker Partners